Bank of New York Mellon’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-2,682
| Closed | -$67K | – | 4554 |
|
2021
Q1 | $67K | Buy |
+2,682
| New | +$67K | ﹤0.01% | 4214 |
|
2018
Q2 | – | Sell |
-2
| Closed | -$17K | – | 4396 |
|
2018
Q1 | $17K | Hold |
2
| – | – | ﹤0.01% | 4265 |
|
2017
Q4 | $27K | Buy |
2
+1
| +100% | +$13.5K | ﹤0.01% | 4267 |
|
2017
Q3 | $37K | Hold |
1
| – | – | ﹤0.01% | 4152 |
|
2017
Q2 | $70K | Sell |
1
-6
| -86% | -$420K | ﹤0.01% | 4089 |
|
2017
Q1 | $509K | Hold |
7
| – | – | ﹤0.01% | 3548 |
|
2016
Q4 | $538K | Buy |
7
+1
| +17% | +$76.9K | ﹤0.01% | 3557 |
|
2016
Q3 | $771K | Hold |
6
| – | – | ﹤0.01% | 3314 |
|
2016
Q2 | $697K | Hold |
6
| – | – | ﹤0.01% | 3367 |
|
2016
Q1 | $760K | Buy |
6
+2
| +50% | +$253K | ﹤0.01% | 3222 |
|
2015
Q4 | $593K | Sell |
4
-1
| -20% | -$148K | ﹤0.01% | 3433 |
|
2015
Q3 | $740K | Hold |
5
| – | – | ﹤0.01% | 3342 |
|
2015
Q2 | $1.57M | Buy |
+5
| New | +$1.57M | ﹤0.01% | 3070 |
|